Clinical trials: Anti-Mullerian Hormone
Ovarian Reserve Markers, Ovarian Function
Ovarian Stromal Stiffness and Ovarian Reserve Parameters Via Transvaginal Shear Wave Elastography
This study aims to evaluate the relationship between ovarian stromal stiffness measured by transvaginal shear wave elastography (SWE) and conventional hormonal and ultrasonographic parameters of ovarian reserve.
- Conditions
- Ovarian Reserve Markers, Ovarian Function, Infertility, Anovulatory
- Trial name
- NCT07773337
- Testing
- Transvaginal Shear Wave Elastography
- Where
- Turkey (Türkiye)
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Endometriomas
Antimullerian Hormone in Endometriomas
The purpose of this multicenter study is to evaluate the ovarian reserve after alcohol sclerotherapy of endometriomas versus conventional surgery.
- Trial name
- NCT02669628
- Testing
- Surgical technique, Alcohol sclerotherapy
- Where
- Spain
- Volunteers
- 34 people
- Sponsor
- Hospital Universitari de Bellvitge
Ovarian Reserve
Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer
The aim of this protocol is to study the deleterious impact of adjuvant chemotherapy or neoadjuvant chemotherapy on ovarian reserve in young women suffering from breast cancer.
- Trial name
- Resova (NCT01114464)
- Where
- 11 sites in France
- Volunteers
- 250 people
- Sponsor
- Nantes University Hospital
Ovarian Reserve
Anti-Mullerian Hormone Changes After Laparoscopic Ovarian Cystectomy for Endometrioma Compared With the Non-ovarian Conditions
This aim of the study is to evaluate the impact of endometrioma and laparoscopic cystectomy on ovarian reserve as measured by serum antimullerian hormone and to study the different effects of levels of serum antimullerian hormone…
- Trial name
- NCT01919333
- Where
- Thailand
- Volunteers
- 56 people, healthy volunteers welcome
- Sponsor
- Thammasat University
Infertility
Individualization of Ovarian Stimulation Using AMH Maximizes the Benefits and Minimizes Complications and Risks
The purpose oh the study is to determine the usefulness of anti-Mullerian hormone (AMH) to identify women at risk of excessive and poor response in controlled ovarian stimulation (COS) for in vitro fertilization (IVF), and the…
- Trial name
- NCT01887652
- Testing
- conventional ovarian stimulation, individualized ovarian stimulation
- Where
- Brazil
- Volunteers
- 250 people
- Sponsor
- ANDROFERT - Clinica de Andrologia e Reproducao Humana
AMH
AMH and Pregnancy Outcome in IVF
Anti-Mu¨llerian hormone (AMH) is an established marker of ovarian reserve (La Marca et al., 2010; Nelson et al., 2009) and predicts both high and low responses in ovarian stimulation cycles (Eldar-Geva et al., 2005; Nardo et al.…
- Trial name
- NCT04512807
- Testing
- AMH
- Volunteers
- 650 people, healthy volunteers welcome
- Sponsor
- Al Baraka Fertility Hospital
Endometriosis Ovary, Laparoscopy
Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma
Background: Endometriosis is defined by the presence of endometrial tissue outside the uterine cavity due to causes not yet fully elucidated.
- Conditions
- Endometriosis Ovary, Laparoscopy, Ovary; Functional Disturbance, Hemostasis
- Trial name
- Endometrioma (NCT03430609)
- Testing
- Laparoscopic treatment for endometrioma Astus©, AMH Level, Transvaginal ultrasound for antral follicle count
- Where
- Brazil
- Volunteers
- 38 people
- Sponsor
- Faculdade de Ciências Médicas da Santa Casa de São Paulo
Endometriosis
Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas
The purpose of this study is to evaluate the ovarian reserve changes after preoperative depot medroxyprogesterone acetate (DMPA) in women with ovarian endometrioma undergoing laparoscopic cystectomy.
- Trial name
- NCT01791413
- Testing
- depot medroxyprogesterone acetate
- Where
- Thailand
- Volunteers
- 40 people
- Sponsor
- Mahidol University
Infertility, Female, AMH
AMHR2 Polymorphism in Blood and Granulosa Cells in Unexplained Infertility
There are various known parameters for assessing ovarian reserve, including ovarian volume, antral follicle count, follicle stimulating hormone (FSH) and Inhibin B at the beginning of the menstrual cycle, as well as…
- Conditions
- Infertility, Female, AMH, IVF
- Trial name
- NCT05592730
- Testing
- AMHR2 polymorphism in blood, AMHR2 polymorphism in granulosa cell
- Where
- Turkey (Türkiye)
- Volunteers
- 96 people, healthy volunteers welcome
- Sponsor
- Bezmialem Vakif University
Infertility, Aneuploidy
Anti-Müllerian Hormone and Embryo Aneuploidy
The goal of this observational study is to determine is there an association between the rates of aneuploidy and the different ranges of serum Antimullerian hormone (AMH) levels.
- Trial name
- NCT05723016
- Testing
- preimplantation genetic test for aneuploidies (PGT-a)
- Where
- Chile
- Volunteers
- 300 people
- Sponsor
- Clinica de la Mujer Medicina Reproductiva, Chile
Psoriasis, Anti Mullerian Hormone
Ovarian Reserve in Patients With Psoriasis
Psoriasis is a common autoimmune disease. It affects women of all ages including reproductive years. Autoimmune diseases including psoriasis are linked to premature ovarian reserve.
- Conditions
- Psoriasis, Anti Mullerian Hormone, Ovarian Reserve
- Trial name
- NCT03492632
- Testing
- Hormone panel
- Where
- Turkey (Türkiye)
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- Kanuni Sultan Suleyman Training and Research Hospital
Infertility
AMH and Pregnancy Rate by Age During Stimulate In-Vitro Fertilization Protocol
The woman fertility decrease with the age and there is a closely link with the ovarian reserve, the number of available eggs in the ovaries.
- Trial name
- NCT01762111
- Where
- Canada
- Sponsor
- Clinique Ovo
Infertility
Tailored Ovarian Stimulation Based on BMI, AMH, AFC
The study objective is to develop a tailored based strategy for ovarian stimulation in IVF patients using AMH, BMI, antral follicle count (AFC). 300 patients will be randomized in 2 arms: 1. control group: standard care rec FSH.
- Trial name
- NCT02430740
- Testing
- recFSH
- Where
- Belgium
- Volunteers
- 300 people
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Epilepsy, Reproductive Issues
Serum Antimullerian Hormone Levels Among Epileptic Patients
The production of AMH starts in granulosa cells before birth and the levels within the serum decreases towards the menapouse. The levels of AMH do not change throughout the menstruation cycle hovewer, it can be affected in cases…
- Trial name
- NCT05066360
- Testing
- serum antimullerian hormone
- Where
- Cyprus
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Near East University, Turkey
Infertility
Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study
The overall objectives of this trial are to: To explore the efficacy and safety of using either antral follicle count (AFC) or anti-Mullerian hormone (AMH) to guide the starting dose of GONAL-f® in ovarian stimulation for…
- Trial name
- NCT01783301
- Testing
- FSH
- Where
- Vietnam
- Volunteers
- 348 people
- Sponsor
- Vietnam National University
Infertility, Female
The Potential Effects of Inofolic Plus on Abnormal Ovarian Reserve Parameters in Subfertile Women
Dr. Roseff and his colleagues are conducting a study to evaluate the effectiveness of a novel substance (Inofolic Plus®) in improving oocyte (egg) parameters in subfertile female patients, as measured through Anti-Mullerian…
- Trial name
- NCT01290432
- Testing
- Inofolic Plus
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Palm Beach Center for Reproductive Medicine
Unilateral Ovarian Endometrioma
Vasopressin Injection Technique to Preserve Ovarian Reserve in Surgery for Unilateral Ovarian Endometriomas
Endometriosis is a common disease with an incidence rate of 15% in women of childbearing age, and is a chronic disease that significantly affects women's quality of life by causing two problems: pain and infertility.
- Trial name
- NCT04372836
- Testing
- Vasopressin injection
- Where
- South Korea
- Volunteers
- 76 people
- Sponsor
- Yonsei University
Infertility, Female, Anti-Mullerian Hormone Deficiency
Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles
The goal of this study is to compare the cumulative pregnancy rates after 4 artificial inseminations with donor (IAD) in non-sterile women with plasma AMH levels > and < 1.1 ng/mL.
- Trial name
- NCT06263192
- Testing
- Intrauterine insemination
- Where
- Spain
- Volunteers
- 342 people
- Sponsor
- Jose Antonio Moreno
Anti-Mullerian Hormone
Clinical Performance Evaluation of AMH Assay
The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay in the intended use population.
- Trial name
- NCT03131388
- Testing
- Access AMH Assay
- Where
- 13 sites in United States, Canada
- Volunteers
- 277 people
- Sponsor
- Beckman Coulter, Inc.
Polycystic Ovary Syndrome
Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS
Polycystic ovary syndrome (PCOS) is found in 5% to 6% of women of reproductive age. It affects women's reproductive capability; thus patients have risks of infertility, miscarriage, and complicated pregnancy.
- Trial name
- NCT03316469
- Testing
- Clomiphene Citrate, Follicular growth
- Volunteers
- 40 people
- Sponsor
- Ain Shams University